Press Releases - Oncology

Press Releases - Oncology

January 10, 2019
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
November 07, 2018
Launching Test Bed for up to 10-plex assays with Simoa Sensitivity and Specificity to Advance Cancer Research
October 22, 2018
Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection
DENVER – A new test could reliably detect early increases in prostate specific antigen (PSA) levels – a biomarker commonly used to measure the recurrence of prostate cancer – in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with…
February 9, 2016
Quanterix announces that Analytical Chemistry, a leading peer-reviewed scientific journal, has published a truly groundbreaking new study authored by Dr. David Walt of Tufts University that prominently features Quanterix’s Single Molecule Array Detection technology, Simoa.     
CAMBRIDGE, MA – November 2, 2010 – Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it was awarded a total of $733,437 in grants under the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP…

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more